New study recommends alternative pain relief for knee replacement patients

July 26, 2017

A new study led by researchers at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust and the University of Warwick has recommended an alternative method of pain relief for patients undergoing knee replacement surgery.

Over 250 patients having knee replacements at UHCW took part in the study, reported this month in The Bone and Joint Journal, a highly-regarded specialist international publication for Orthopaedic surgeons.

The study was funded by the National Institute for Health Research (NIHR) Research for Patient Benefit (RfPB) Programme.

A traditional option for pain relief during knee replacement surgery is a 'femoral nerve block'; a single dose of local anaesthetic injected around the femoral nerve in the groin, which is typically administered by an anaesthetist. However, a newer alternative approach uses an injection of anaesthetic agents around the knee joint and is administered by the surgeon without the need for specialist equipment.

The study found that patients who had the knee injections required lower doses of powerful painkillers such as morphine after surgery. Morphine can cause serious and troublesome side effects in postoperative patients and is best avoided if possible. Also, unlike a femoral nerve block, there is no need for specialist equipment like ultrasound. This is therefore likely to save surgeons and anaesthetists valuable time and resources and improve patient care.

A tribute was published in the article to Mr Andrew Sprowson, a Consultant Orthopaedic Surgeon at UHCW, and Associate Professor at the University of Warwick, who had been Chief Investigator in the study until his untimely death in March 2015.

Mr Peter Wall, Clinical Lecturer at UHCW NHS Trust and University of Warwick, and lead author of the report, said:

"Our study has demonstrated the advantages of injections of anaesthetic agents around the knee during knee replacement surgery over other methods. These injections are now shown to be safe and effective. They also involve fewer resources and reduce the need for powerful painkillers such as morphine.

"This is to be welcomed as the potential risks of morphine-type pain relief are well known and should be avoided where possible. We hope that these study findings, if put into practice, will benefit patients around the world.

"I want to emphasise the debt we owe to our late colleague Andrew Sprowson. Without his initiative and enthusiasm, this research study would not have taken place."
-end-
For further details Nicola Jones, Media Relations Manager, University of Warwick: 07920531221 or N.Jones.1@warwick.ac.uk

Notes to editors

The study is available to download here: http://bjj.boneandjoint.org.uk/content/99-B/7/904

The National Institute for Health Research (NIHR): improving the health and wealth of the nation through research.

Established by the Department of Health, the NIHR:For further information, visit the NIHR website http://www.nihr.ac.uk

University Hospitals Coventry and Warwickshire NHS Trust (UHCW) is one of the largest acute teaching Trusts in the UK, comprising University Hospital in Coventry and the Hospital of St Cross in Rugby.

University of Warwick

Related Morphine Articles from Brightsurf:

Virtual reality illuminates the power of opioid-associated memories
The brain acts differently when remembering environments associated with drug use.

Intranasal sufentanil as good as IV morphine for emergency pain relief, study finds
In patients presenting to an emergency department with severe traumatic pain, intranasal sufentanil was as good as standard-of-care intravenous morphine for pain relief, according to a new study published this week in PLOS Medicine by Marc Blancher of Grenoble Alpes University Hospital, France, and colleagues.

New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.

New painkiller lasts longer, is less addictive than morphine
As an alternative to morphine, researchers present a new nano-painkiller they've tested in rodents.

How the poppy evolved its pain-relieving properties
The unveiling of the poppy genome reveals how a collection of genes fused to endow the plant with its pain-relieving compounds; the plant underwent a notable genome duplication event about 7.8 million years ago, the study's authors say.

A wakefulness molecule is abundant in the brains of heroin addicts
Researchers have discovered that the brains of heroin addicts harbor a greater number of neurons that produce hypocretin, a molecule involved in arousal and wakefulness, and one lacking in abundance in people with narcolepsy.

Change in brain cells linked to opiate addiction, narcolepsy
Two discoveries -- one in the brains of people with heroin addiction and the other in the brains of sleepy mice -- shed light on chemical messengers in the brain that regulate sleep and addiction.

Potential new treatment for drug addiction relapse revealed
Research published in Addiction Biology by scientists at the University of Bath reveals a new potential mechanism for combatting drug addiction relapse.

Body's 'natural opioids' affect brain cells much differently than morphine
A new study led by UC San Francisco scientists shows that brain cells, or neurons, react differently to opioid substances created inside the body -- the endorphins responsible for the 'natural high' that can be produced by exercise, for example -- than they do to morphine and heroin, or to purely synthetic opioid drugs, such as fentanyl.

Study suggests failed osteoarthritis drug could help treat opioid addiction
A study from Indiana University suggests that a drug proven safe for use in people may prevent opioid tolerance and physical dependence when used with opioid-based pain medications.

Read More: Morphine News and Morphine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.